MENU
AARD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Aardvark Therapeutics (AARD) Earnings Date & Reports

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases... Show more

A.I. Advisor
published Earnings

AARD is expected to report earnings to rise 16.67% to -76 cents per share on December 03

Aardvark Therapeutics AARD Stock Earnings Reports
Q3'25
Est.
$-0.77
Q2'25
Beat
by $0.04
The last earnings report on August 13 showed earnings per share of -66 cents, beating the estimate of -69 cents. With 83.53K shares outstanding, the current market capitalization sits at 184.17M.
View a ticker or compare two or three
AARD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AARD showed earnings on August 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details